APP and Alzheimer disease: Interestingly, ppGalNAc-T4, -T6, and -T10 were found to be tightly related to the progression of AD [114], and the inhibition of some of these isoforms decreased O-glycosylation of APP, leading to a decrease in the production of Aβ peptides [153].